When HIV Treatment Stops Working: Drug Resistance, Treatment Failure and Switching

Can HIV medicine stop working? Yes, it can. But for most people who take their treatment every day, it keeps working for many years. When it does stop working, the first sign is almost always a change in a blood test, not how you feel, and there are other medicines that can bring the virus back under control.

This guide explains what “treatment failure” means, how drug resistance develops, what the tests show, and how a new regimen is chosen.

What “treatment failure” means

The aim of HIV treatment is to push the amount of virus in your blood (your viral load) so low that standard tests cannot detect it. US treatment guidelines use a few terms you may hear¹:

• Virologic failure: the viral load cannot be brought below, or kept below, 200 copies/mL.
• Rebound: the viral load was undetectable, then comes back at 200 copies/mL or more on a repeat test.
• Blip: a single, low detectable result that goes back to undetectable on the next test. Blips are common and usually do not lead to failure.
• Low-level viremia: a confirmed result that is detectable but below 200 copies/mL.

So one slightly raised result is not a reason to panic. Your clinic will repeat the test before deciding anything. Our guide to viral load and CD4 count explains these numbers in more detail.

How drug resistance develops

HIV copies itself constantly, and it makes small mistakes as it does. These changes are called mutations. Some of them let the virus keep copying even when a particular medicine is present. That is drug resistance².

Resistance needs the virus to be copying. That is why steady treatment matters so much: when the viral load stays undetectable, resistance is much less likely to appear¹³. The NIH says even occasionally skipping doses can let HIV multiply and raise the risk of resistance².

Resistance can also affect more than one medicine at a time. For example, resistance to emtricitabine can also cause resistance to lamivudine, because the two work in a very similar way².

Some people have resistant virus before they ever take treatment, because the virus they caught was already resistant. This is called transmitted resistance, and it is why a resistance test is usually done soon after diagnosis².

Why treatment stops working

US guidelines list many possible causes. They fall into three groups¹:

• The virus: resistance that was already there, past treatment failure, or a very high viral load before starting.
• The medicines: interactions with other medicines that lower HIV drug levels, problems with absorption, food rules not being followed, side effects, a heavy pill burden, or a prescribing or dispensing error.
• Life: missed doses, gaps in supply, cost, missed appointments, unstable housing, substance use or mental health problems.

Usually the cause can be found. Many of these are fixable without changing the medicine at all, for example by spacing an antacid away from your tablet or finding a way to keep a steady supply. See our guides to missed doses and HIV medicine interactions.

The warning sign is a blood test, not a symptom

Drug resistance does not have its own symptoms. Most people feel completely well when their viral load starts to rise. If the virus keeps copying for a long time, the immune system weakens again and it becomes harder to stay healthy², but by then the problem has usually been visible on blood tests for months.

That is the real reason regular viral load tests matter. They catch a problem early, while there are still the most options.

The resistance test

If treatment seems to be failing, your clinic will usually send a blood sample for a genotypic resistance test. It reads the genetic code of your virus and looks for mutations linked to resistance against each drug class⁴.

• Timing matters. The test should be done while you are still taking your medicines, or within 4 weeks of stopping. Once the medicines are stopped, resistant virus can drop out of sight and be missed⁴.
• It needs enough virus. These tests generally need a viral load of at least 500 to 1,000 copies/mL to work. At lower levels the test may not give a result, though it may still be tried⁴.
• Old resistance is never fully gone. Resistant virus can stay hidden in the body even when it no longer shows on a test, and can come back if the wrong medicine is used. That is why your team looks at every resistance test you have ever had, not just the latest one⁵.

Reading these reports is a specialist job, and US guidelines encourage clinics to get expert advice when designing a new regimen⁴.

High-barrier and low-barrier medicines

Some HIV medicines are much harder for the virus to escape than others. US guidelines describe second-generation integrase inhibitors, such as dolutegravir, and boosted protease inhibitors, such as darunavir with ritonavir or cobicistat, as having a high barrier to resistance¹. Other medicines can lose their effect after fewer changes in the virus.

This is one reason modern first treatments are built around dolutegravir or bictegravir. It is also why, after failure, a new regimen usually includes at least one high-barrier medicine plus other medicines that the resistance test shows are still fully active¹.

High barrier does not mean no risk. The World Health Organization reports that resistance to dolutegravir may be higher than expected, especially in people who have taken many HIV treatments before, and calls for closer monitoring³.

Switching because of failure vs switching for other reasons

There are two very different kinds of switch:

• Switching because treatment is failing. The goal is to get the viral load back to undetectable using a new regimen built from the resistance test results¹. There is a wide choice of medicines, including some used specifically for drug-resistant HIV, such as the long-acting medicines lenacapavir and ibalizumab².
• Switching while treatment is working, for side effects, fewer pills, an interaction, pregnancy plans or cost. Common examples are moving from Triumeq to Dovato to drop abacavir, or from an older regimen to a single daily pill. Even here, the team checks your full treatment history, past resistance results, hepatitis B status and other medicines before the switch, because hidden resistance can make the new regimen fail⁵. Our comparison of Dovato, Biktarvy and Triumeq covers the most common switches.

What to expect after a switch

After any switch, your clinic watches closely for new side effects and checks your viral load in the following weeks and months to make sure the new regimen is holding⁵. If you have hepatitis B, the new regimen must still include medicines that control it, because stopping them can cause a liver flare⁵.

A few practical tips:

• Finish or return your old medicines as your clinic tells you. Do not keep a mix of old and new tablets.
• Read the new leaflet for food rules and interactions; they may differ from your old pill.
• Tell your pharmacist so your records are up to date.
• Keep every viral load appointment in the first months.

How to lower your risk of resistance

The WHO’s advice for preventing resistance comes down to using effective medicines, staying in care, taking treatment consistently, regular viral load testing, and switching quickly when failure is confirmed³. For you, that means:

• Take your medicine every day, at about the same time.
• Never stop or take a “break” without a plan from your clinic.
• Keep a few days’ spare supply so you never run out.
• Check every new medicine or supplement for interactions.
• Go to your viral load tests, even when you feel well.
• Tell your team early if something makes your treatment hard to take. The NIH suggests raising worries about taking medicine consistently, or a preference for less frequent dosing, so the plan can be built around your life².

Medicines often used when a new regimen is built include dolutegravir, such as Doluvir 50 mg, and boosted darunavir, such as Durart-R. Your HIV team will choose based on your resistance tests, and all need a prescription.

Frequently asked questions

Can HIV meds stop working?

Yes. If the virus becomes resistant, or if levels of the medicine in the blood drop because of missed doses or interactions, treatment can stop working. Regular viral load tests pick this up early, and other regimens are available.

What are the symptoms of HIV drug resistance?

There are usually none at first. The first sign is a rising viral load on a blood test. Symptoms of a weakened immune system only appear if the virus has been copying for a long time without being treated effectively.

Can you switch HIV medication?

Yes. People switch for side effects, fewer pills, interactions or cost, and when treatment is failing. A switch is planned by your HIV team after looking at your treatment history and resistance tests, and your viral load is checked afterwards.

Does one detectable viral load mean my treatment has failed?

No. A single low detectable result followed by an undetectable one is called a blip and is usually not a problem. Failure means a confirmed viral load of 200 copies/mL or more.

Can drug-resistant HIV still be treated?

Yes. Because there are several classes of HIV medicine, a regimen can be built from medicines the virus is still sensitive to, and some medicines are made specifically for drug-resistant HIV.

Can someone catch a drug-resistant virus?

Yes. This is called transmitted resistance, which is why a resistance test is usually done soon after an HIV diagnosis, before treatment is chosen.

Sources & references

1. US Department of Health and Human Services, Clinicalinfo. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents: Virologic Failure. Updated 12 September 2024.
2. National Institutes of Health (HIVinfo). HIV Drug Resistance. Last reviewed 10 July 2026.
3. World Health Organization. HIV drug resistance (fact sheet). 27 July 2026.
4. US Department of Health and Human Services, Clinicalinfo. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents: Drug-Resistance Testing. Updated 12 September 2024.
5. US Department of Health and Human Services, Clinicalinfo. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents: Adverse Effects of Antiretroviral Medications (section on switching regimens). Updated 25 September 2025.

Related reading

• Missed a dose of HIV medication?
• HIV viral load and CD4 count explained
• HIV medication side effects
• Dolutegravir medicines and generic Tivicay
• Darunavir medicines and generic Prezista

This content is for informational purposes only and is not medical advice. Viral load and resistance results must be interpreted by your HIV team. Never stop, pause or change HIV medicine on your own. Used as prescribed by a licensed medical professional.